Randomized trial on acute toxicities of weekly vs three‐weekly cisplatin‐based chemoradiation in head and neck cancer

Abstract Background The current first‐line treatment of locally advanced head and neck carcinoma (LAHNC) is concurrent chemoradiation with three‐weekly cisplatin 100 mg/m2. However, prescribing cisplatin at this dose increases the treatment toxicity, which may compromise the treatment results. An al...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Ahmad Ameri, Shokoufe Norouzi, Ainaz Sourati, Samira Azghandi, Kambiz Novin, Farzad Taghizadeh‐Hesary
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2022-01-01
coleção:	Cancer Reports
Assuntos:	acute toxicity chemoradiation cisplatin head and neck cancer hematologic toxicity renal toxicity
Acesso em linha:	https://doi.org/10.1002/cnr2.1425
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!